Skip to main content
logo
BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
67.96
+1.82 (2.75%)
Oct 6, 2026, 11:19 AM EDT - Market open

BridgeBio Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
13,28614,7405,1867,0231,1392,455
Market Cap Growth
31.47%184.24%-26.16%516.57%-53.61%-71.83%
Enterprise Value
15,93916,8016,6618,2292,2713,264
Last Close Price
66.1476.4927.4440.377.6216.68

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
18.2829.3623.37754.9214.6735.22
PB Ratio
--7.10-3.56-5.23-0.91-2.84

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
22.0033.4630.02884.5129.2546.81

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.35-0.90-1.19-1.30-1.38-1.99
Net Debt / Equity Ratio
-1.06-0.61-0.72-0.97-1.00-1.03
Net Debt / EBITDA Ratio
-5.61-2.57-1.84-2.20-2.71-1.57
Net Debt / FCF Ratio
-6.09-2.85-2.01-2.47-2.95-1.74
Asset Turnover
0.620.540.300.020.100.08
Quick Ratio
1.092.524.443.044.036.34
Current Ratio
1.232.774.673.324.526.58
Return on Assets (ROA)
-26.00%-33.83%-49.24%-64.08%-35.80%-41.75%
Return on Capital Employed (ROCE)
-146.30%-77.50%-75.50%-148.90%-93.40%-65.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-5.31%-4.92%-10.33%-9.16%-42.24%-22.91%
FCF Yield
-3.34%-3.03%-10.06%-7.53%-37.25%-20.82%
Buyback Yield / Dilution
-2.29%-2.93%-14.30%-10.39%-2.16%-22.34%
SEC Filings: 10-K · 10-Q